| Financial Year |
March 31 2022 |
| Monetary Funds |
5,625,447.50 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
73,417.41 |
| Advances to Suppliers |
193,994.93 |
| Other Receivables |
184,316,274.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
203,762,203.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
308,206,461.38 |
| Other Current Assets |
10,825,678.62 |
| Total Current Assets |
846,819,696.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
14,678,554.56 |
| Investment Properties |
266,704,002.58 |
| Fixed Assetes |
30,553,073.68 |
| Under-construction Projects |
198,023,374.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
344,043,181.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
47,515,375.10 |
| Sub-Total of Non-Current Assets |
911,517,561.62 |
| Total Assets |
1,758,337,258.55 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
38,934,337.48 |
| Accounts Received In Advance |
1,051,761.70 |
| Employee Compensation Payable |
5,728,709.95 |
| Taxes Payable |
103,575,303.88 |
| Interest Payable |
102,139,192.65 |
| Dividend Payable |
-- |
| Other payables |
580,915,754.39 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
173,383,275.00 |
| Other Current Liabilities |
180,771,384.96 |
| Sub-Total of Current Liabilities |
1,126,512,298.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
20,372,320.74 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
20,372,320.74 |
| Total Liabilities |
1,146,884,618.90 |
| Paid-In Capital(Or Share Stock) |
1,303,500,000.00 |
| Capital Surplus |
424,834,565.36 |
| Surplus Reserve |
142,700,232.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,263,799,551.61 |
| Minority Stockholder's Interest |
-526,805.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
611,979,445.57 |
| Owner's Equity（Stockholder's Equity） |
611,452,639.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,758,337,258.55 |
